SK2782002A3 - Polymorphs of N-methyl-N-[3-[3-(2-thienylcarbonyl)-pyrazol- [1,5-alpha]-pyrimidin-7-yl]phenyl]acetamide and compositions and methods related thereto - Google Patents

Polymorphs of N-methyl-N-[3-[3-(2-thienylcarbonyl)-pyrazol- [1,5-alpha]-pyrimidin-7-yl]phenyl]acetamide and compositions and methods related thereto Download PDF

Info

Publication number
SK2782002A3
SK2782002A3 SK278-2002A SK2782002A SK2782002A3 SK 2782002 A3 SK2782002 A3 SK 2782002A3 SK 2782002 A SK2782002 A SK 2782002A SK 2782002 A3 SK2782002 A3 SK 2782002A3
Authority
SK
Slovakia
Prior art keywords
polymorph
pyrimidin
acetamide
phenyl
methyl
Prior art date
Application number
SK278-2002A
Other languages
English (en)
Slovak (sk)
Inventor
William J Thiele
Patrick B O'donnell
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Publication of SK2782002A3 publication Critical patent/SK2782002A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK278-2002A 1999-09-02 2000-09-01 Polymorphs of N-methyl-N-[3-[3-(2-thienylcarbonyl)-pyrazol- [1,5-alpha]-pyrimidin-7-yl]phenyl]acetamide and compositions and methods related thereto SK2782002A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38952499A 1999-09-02 1999-09-02
US42162099A 1999-10-19 1999-10-19
PCT/US2000/024051 WO2001015700A1 (en) 1999-09-02 2000-09-01 POLYMORPHS OF N-METHYL-N-(3-{3-[2-THIENYLCARBONYL]-PYRAZOL-[1,5-α]-PYRIMIDIN -7-YL }PHENYL )ACETAMIDE AND COMPOSITIONS AND METHODS RELATED THERETO

Publications (1)

Publication Number Publication Date
SK2782002A3 true SK2782002A3 (en) 2003-04-01

Family

ID=27012737

Family Applications (1)

Application Number Title Priority Date Filing Date
SK278-2002A SK2782002A3 (en) 1999-09-02 2000-09-01 Polymorphs of N-methyl-N-[3-[3-(2-thienylcarbonyl)-pyrazol- [1,5-alpha]-pyrimidin-7-yl]phenyl]acetamide and compositions and methods related thereto

Country Status (26)

Country Link
EP (2) EP1477169A1 (pt)
JP (1) JP4592241B2 (pt)
KR (1) KR20020035585A (pt)
CN (2) CN1331865C (pt)
AP (1) AP1631A (pt)
AT (1) ATE269082T1 (pt)
AU (2) AU769856B2 (pt)
BR (1) BR0014459A (pt)
CA (1) CA2382588C (pt)
CZ (1) CZ2002783A3 (pt)
DE (1) DE60011638T2 (pt)
DK (1) DK1214075T3 (pt)
EA (1) EA004706B1 (pt)
ES (1) ES2222920T3 (pt)
HK (1) HK1047407B (pt)
HU (1) HUP0202698A3 (pt)
IL (2) IL148242A0 (pt)
MX (1) MXPA02002314A (pt)
NO (1) NO322752B1 (pt)
NZ (1) NZ517298A (pt)
OA (1) OA12200A (pt)
PL (1) PL353362A1 (pt)
PT (1) PT1214075E (pt)
SK (1) SK2782002A3 (pt)
TR (1) TR200200534T2 (pt)
WO (1) WO2001015700A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2274260T3 (es) 2002-08-26 2007-05-16 Neurocrine Biosciences, Inc. Nuevo polimorfo de n-metil-n-(3-(3-((2-tienilcarbonil))pirazol-((1,5-alfa))pirimidin-7-il))fenil)acetamida y composiciones y metodos relacionados.
WO2004110454A1 (ja) * 2003-06-13 2004-12-23 Ishihara Sangyo Kaisha, Ltd. アデノシンＡ2ａ受容体アゴニストの投与が必要な疾患を治療又は予防するための組成物
US7371906B2 (en) * 2004-08-24 2008-05-13 Eastman Kodak Company Process for photo-oxidative stability improvements
EP1918290A1 (en) * 2006-10-11 2008-05-07 Ferrer Internacional, S.A. Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
EP1956021A1 (en) * 2006-10-11 2008-08-13 Ferrer Internacional, S.A. Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound
CN101177427B (zh) * 2006-11-09 2011-07-20 中国人民解放军军事医学科学院放射与辐射医学研究所 一种用于催眠的化合物的多晶型α和溶剂化物,其制备方法及含该物质的组合物
US20120028045A1 (en) * 2009-03-24 2012-02-02 Glenmark Generics Ltd Processes for the Preparation of Indiplon and Intermediates Thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4654347A (en) * 1983-06-23 1987-03-31 American Cyanamid Company Aryl and heteroaryl[[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]methanones
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
US4521422A (en) * 1983-06-23 1985-06-04 American Cyanamid Company Aryl and heteroaryl[7-(aryl and heteroaryl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones
NZ208554A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (aryl and heteroaryl)-(7-(aryl and heteroaryl)-pyrazolo (1,5-a) pyrimidin-3-yl)-methanone derivatives and pharmaceutical compositions
ATE97414T1 (de) * 1985-05-13 1993-12-15 American Cyanamid Co (7-(3-disubstituierte amino)phenyl>pyrazolo(1,5- a>-pyrimidine.
US5421422A (en) * 1993-11-19 1995-06-06 Boretec Inc Roller cutter mount for tunneling machine

Also Published As

Publication number Publication date
AP2002002428A0 (en) 2002-03-31
DK1214075T3 (da) 2004-10-25
ES2222920T3 (es) 2005-02-16
CA2382588A1 (en) 2001-03-08
NO322752B1 (no) 2006-12-04
IL148242A (en) 2006-12-10
HK1047407A1 (en) 2003-02-21
KR20020035585A (ko) 2002-05-11
CZ2002783A3 (cs) 2004-01-14
IL148242A0 (en) 2002-09-12
TR200200534T2 (tr) 2002-06-21
CN1680376A (zh) 2005-10-12
EA200200320A1 (ru) 2002-08-29
NO20021041D0 (no) 2002-03-01
NZ517298A (en) 2004-01-30
DE60011638T2 (de) 2004-10-21
AP1631A (en) 2006-07-12
BR0014459A (pt) 2002-07-16
WO2001015700A9 (en) 2002-09-12
HK1047407B (zh) 2004-12-24
EP1214075A1 (en) 2002-06-19
WO2001015700A1 (en) 2001-03-08
AU6949100A (en) 2001-03-26
HUP0202698A3 (en) 2004-12-28
PL353362A1 (en) 2003-11-17
HUP0202698A2 (hu) 2002-12-28
AU2004201356A1 (en) 2004-04-29
NO20021041L (no) 2002-04-03
DE60011638D1 (de) 2004-07-22
CA2382588C (en) 2008-11-25
CN1331865C (zh) 2007-08-15
JP2003508440A (ja) 2003-03-04
EP1214075A4 (en) 2003-05-02
EP1477169A1 (en) 2004-11-17
AU769856B2 (en) 2004-02-05
ATE269082T1 (de) 2004-07-15
EA004706B1 (ru) 2004-06-24
EP1214075B1 (en) 2004-06-16
OA12200A (en) 2006-05-09
MXPA02002314A (es) 2002-08-12
CN1198824C (zh) 2005-04-27
CN1374866A (zh) 2002-10-16
JP4592241B2 (ja) 2010-12-01
PT1214075E (pt) 2004-11-30

Similar Documents

Publication Publication Date Title
US20060025427A1 (en) Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
IL166621A (en) POLYMORPH OF N-METHYL-N-(3-{3-[2-THIENYLCARBONYL]-PYRAZOL-[1,5-a]PYRIMIDIN-7-YL}PHENYL) ACETAMIDE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
SK2782002A3 (en) Polymorphs of N-methyl-N-[3-[3-(2-thienylcarbonyl)-pyrazol- [1,5-alpha]-pyrimidin-7-yl]phenyl]acetamide and compositions and methods related thereto